Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Indira Varia, MD: Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
1
x
$
30.00
Treatment of Autism Spectrum Disorder in Children and Adolescents
1
x
$
30.00
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
1
x
$
30.00
Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder
1
x
$
30.00
Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
1
x
$
30.00
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
1
x
$
30.00
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
1
x
$
30.00
Theodore J. Anfinson, MD: Akathisia, Panic, Agoraphobia, and Major Depression Following Brief Exposure to Metoclopramide
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers
1
x
$
30.00
Paliperidone Induced Hypothyroidism: A Case Report
1
x
$
30.00
Long-Term Treatment Strategies in Anxiety Disorders
1
x
$
30.00
View Cart
Checkout
Home
ssri
“Long-Term Treatment Strategies in Anxiety Disorders” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
A Bell’s Palsy Case Probably Related to Sertraline Use
$
30.00
Add to cart
Details
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
$
30.00
Add to cart
Details
Escitalopram: A Second-Generation SSRI
$
0.00
Add to cart
Details
Antidepressant Induced Apathy Responsive to Dose Reduction
$
30.00
Add to cart
Details
A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach
$
30.00
Add to cart
Details
C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
$
30.00
Add to cart
Details
Jefferson B. Prince, MD: Citalopram for the Treatment of Adolescent Anxiety Disorders: A Pilot Study
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: Overview of the Safety of Citalopram
$
30.00
Add to cart
Details
P. Murali Doraiswamy, MD: A Randomized Controlled Trial of Paroxetine for Noncardiac Chest Pain
$
30.00
Add to cart
Details
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
$
30.00
Add to cart
Details
Can We Distinguish Anxiety From Depression?
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
Depression Treatment: A Lifelong Commitment?
$
30.00
Add to cart
Details
Mechanism of Action of Antidepressants
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Page load link
Go to Top
